組織蛋白酶K(CTSK)單克隆抗體
Monoclonal Antibody to Cathepsin K (CTSK)
CTS-K; CTS02; CTSO; CTSO1; CTSO2; PKND; PYCD; Pycnodysostosis; Cathepsin O; Cathepsin X
- 編號MAA267Hu22
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C1
- Ig亞型 IgG2b Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPA267Hu01-組織蛋白酶K(CTSK)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/mL
- 且適物種Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠), Oryctolagus cuniculus (Rabbit，兔), Canis familiaris; Canine (Dog，犬), Sus scrofa; Porcine (Pig，豬), Bos taurus; Bovine (Cattle，牛), Ovis aries; Ovine (Sheep，綿羊), Equus caballus; Equine (Horse，馬)
- 應(yīng)用WB
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 605 ¥ 1411 ¥ 2016 ¥ 5040 ¥ 20160
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
IHC圖
-
Western Blot; Samples: Lane1: Rat Skeletal muscle lysate; Lane2: Rat Cartilage lysate; Primary Ab: 0.05μg/ml Mouse Anti-Human CTSK Antibody Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
Western Blot; Sample: Lane1: Human Lung lysate; Lane2: Porcine Heart lysate; Lane3: Porcine Uterus lysate; Lane4: Human Cartilage lysate; Lane5: Human Lung lysate; Lane6: Porcine Cartilage lysate; Lane7: Rat Ear lysate; Lane8: Rat Uterus lysate; Lane9: Mouse Cartilage lysate; Lane10: Mouse Uterus lysate<br/>Primary Ab: 0.2μg/ml Mouse Anti-Human CTSK Antibody<br/>Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody<br/>(Catalog: SAA544Mu19)
-
Western Blot; Sample: Lane1: Human Cartilage lysate; Lane2: Porcine Cartilage lysate; Lane3: Rat Ear lysate; Lane4: Mouse Cartilage lysate; Lane5: Canine Cartilage lysate; Lane6: Bovine Cartilage lysate; Lane7: Caprine Cartilage lysate; Lane8: Rabbit Uterus lysate; Lane9: Equine Lung lysate<br/>Primary Ab: 0.02μg/ml Mouse Anti-Human CTSK Antibody<br/>Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody<br/>(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對CTSK的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗中能識別CTSK。
用法
Western blotting: 0.01-3μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗服務(wù)
免疫沉淀(IP)實(shí)驗服務(wù)
免疫熒光(IF)實(shí)驗服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時熒光定量PCR實(shí)驗服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA267Hu01 | 組織蛋白酶K(CTSK)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA267Hu02 | 組織蛋白酶K(CTSK)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA267Hu01 | 組織蛋白酶K(CTSK)多克隆抗體 | WB; ICC; IHC-P; IHC-F; ELISA. |
| PAA267Hu02 | 組織蛋白酶K(CTSK)多克隆抗體 | WB; IHC; ICC; IP. |
| FAA267Hu01 | 抗組織蛋白酶K(CTSK)多克隆抗體 | Flow cytometry. |
| MAA267Hu22 | 組織蛋白酶K(CTSK)單克隆抗體 | WB |
| MAA267Hu21 | 組織蛋白酶K(CTSK)單克隆抗體 | WB |
| FAA267Hu02 | 抗組織蛋白酶K(CTSK)單克隆抗體 | Flow cytometry. |
| FAA267Hu04 | 抗組織蛋白酶K(CTSK)單克隆抗體 | Flow cytometry. |
| LAA267Hu72 | 組織蛋白酶K(CTSK)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| SEA267Hu | 組織蛋白酶K(CTSK)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA267Hu | 組織蛋白酶K(CTSK)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSA267Hu01 | 組織蛋白酶K(CTSK)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSA267Hu01 | 組織蛋白酶K(CTSK)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Acta Histochemica | MRMT-1 rat breast carcinoma cells and models of bone metastases: improvement of an in vitro system to mimic the in vivo condition. [PubMed: S0065128112000773] |
| Atherosclerosis.? | Biochemical and clinical correlation of intraplaque neovascularization using contrast-enhanced ultrasound of the carotid artery [Pubmed:24534452] |
| Genet. Mol. Res | Drynaria total flavonoids decrease cathepsin K expression in ovariectomized rats [Pubmed:25036175] |
| Age (Dordr) | In vitro method for the screening and monitoring of estrogen-deficiency osteoporosis by targeting peripheral circulating monocytes [PubMed: 26250906] |
| Journal of Infectious Diseases | Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis [PubMed: 26416658] |
| PLoS One. | Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritis [pmc:PMC4822855] |
| Cell?Death?And Differentiation | TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42 [Pubmed:29358671] |
| Indian Journal of Dental Research | Comparative evaluation of cathepsin K levels in gingival crevicular fluid among smoking and nonsmoking patients with chronic periodontitis [Pubmed: 30409937] |
| International Journal of Biological Macromolecules | A bioactive exopolysaccharide from marine bacteria Alteromonas sp. PRIM-28 and its role in cell proliferation and wound healing in vitro [Pubmed: 30851325] |
| 畢業(yè)論文 | Biomarkers of Compromised Implant Fixation [] |
| neuroscience letters | Compound K induces neurogenesis of neural stem cells in thrombin induced nerve injury through LXRα signaling in mice [Pubmed: 32371156] |
| Информационный алгоритм неинвазивной оценки остеорезорбтивного побочного действия глюкокортикостероидов у больных язвенным колитом [] | |
| Особенности остеоиммунологических аспектов остеорезорбции при периимплантите, хроническом пародонтите и раке альвеолярного отростка и?… [] |
留言咨詢
